Cargando…
Immune Checkpoints, Inhibitors and Radionuclides in Prostate Cancer: Promising Combinatorial Therapy Approach
Emerging research demonstrates that co-inhibitory immune checkpoints (ICs) remain the most promising immunotherapy targets in various malignancies. Nonetheless, ICIs have offered insignificant clinical benefits in the treatment of advanced prostate cancer (PCa) especially when they are used as monot...
Autores principales: | Kgatle, Mankgopo M., Boshomane, Tebatso M. G., Lawal, Ismaheel O., Mokoala, Kgomotso M. G., Mokgoro, Neo P., Lourens, Nico, Kairemo, Kalevo, Zeevaart, Jan Rijn, Vorster, Mariza, Sathekge, Mike M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071559/ https://www.ncbi.nlm.nih.gov/pubmed/33921181 http://dx.doi.org/10.3390/ijms22084109 |
Ejemplares similares
-
PSMA Theranostics: Science and Practice
por: Mokoala, Kgomotso, et al.
Publicado: (2021) -
Cardiovascular disturbances in COVID-19: an updated review of the pathophysiology and clinical evidence of cardiovascular damage induced by SARS-CoV-2
por: Lawal, Ismaheel O., et al.
Publicado: (2022) -
Radionuclide Imaging of Invasive Fungal Disease in Immunocompromised Hosts
por: Lawal, Ismaheel O., et al.
Publicado: (2021) -
COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks
por: Kgatle, Mankgopo Magdeline, et al.
Publicado: (2021) -
The SARS-COV-2 Seroprevalence among Oncology Patients
por: Kgatle, Mankgopo, et al.
Publicado: (2023)